Generex Biotechnology: vaccines a clear way ahead for RapidMist

September 2004
PharmaWatch: Monthly Review;September 2004, Vol. 3 Issue 9, p50
Market Research Report
Reports on chief scientific officer of Generex Biotechnology's Antigen Express immunomedicines subsidiary, Robert Humphreys' presentation of a research abstract at the Foundation Merieux Conference discussing the prospects for the company's RapidMist delivery system. Benefits of the technology to companies in vaccine development; Features of the technology; Overview on the performance of MedImmune's FluMist nasal vaccine.


Related Articles

  • Generex Biotechnology: vaccines a clear way ahead for RapidMist.  // PharmaWatch: Biotechnology;September 2004, Vol. 3 Issue 9, p6 

    Reports on the innovation made by Generex Biotechnology Corp. for the RapidMist platform technology for vaccine delivery. Uncertain profitability of the delivery system; Discussion of the prospects for Generex's RapidMist delivery system during the Foundation Merieux Conference in 2004.

  • Oral-lyn, the Oral Insulin Spray.  // Diabetes Health;Feb/Mar2010, Vol. 19 Issue 1, p24 

    The article evaluates the Generex Oral-lynâ„¢ insulin spray from Generex Biotechnology Corp.

  • GENEREX PRESENTS POTENTIAL USES OF RAPIDMIST.  // Biotech Equipment Update;Aug2004, p4 

    Generex Biotechnology Corp., Toronto, has presented a research abstract by Robert Humphreys, the chief scientific officer of its Antigen Express immunomedicines subsidiary, at the Foundation Merieux Conference, "Innate and Adaptive Immunity after Transcutaneous or Mucosal Vaccination." Pankaj...

  • Microstructured transdermal systems for intradermal vaccine and drug delivery. Peterson, Timothy A. // Pharmaceutical Technology Europe;Dec2006, Vol. 18 Issue 12, p21 

    The article provides an overview of microstructured transdermal systems (MTS) technology with the emphasis on solid-coated MTS for drug and vaccine delivery. MTS is particularly well suited to vaccine delivery because it provides a pain-free alternative to injection. In addition, various...

  • GENEREX AWARDED TWO NEW PATENTS FOR BUCCAL DRUG DELIVERY.  // Biotech Business;Jul2010, Vol. 23 Issue 7, p7 

    The article reports that Generex Biotechnology Corporation was awarded patents in Japan and Ukraine. According to Rose C. Perri, the company's chief operating officer, each patent issuance suggests the inventiveness of the company's buccal drug delivery platform technologies. Generex is based in...

  • SHOTS WITHOUT NEEDLES.  // Popular Science;Dec2005, Vol. 267 Issue 6, p68 

    This article presents information on PMED, a vaccine gun developed by PowderMed. PowderMed's PMED, requires no sharps. The flashlight-shaped device relies on pressurized helium to shoot microscopic DNA vaccine particles just below the skin's surface at 1,500 miles an hour. As a result, the PMED...

  • GENEREX GETS CHINA PATENT FOR II-KEY PETIDE VACCINE.  // Worldwide Biotech;Apr2010, Vol. 22 Issue 4, p1 

    The article reports that Generex Biotechnology Corp. has received a patent for its Ii-Key peptide vaccine technology in China. The company has begun discussions for potential joint venture/licensing partnerships with pharmaceutical companies for its peptide cancer vaccine technology platform....

  • San Antonio Breast Cancer Symposium.  // BioWorld Today;12/9/2011, Vol. 22 Issue 237, p5 

    The article deals with the interim data presented by Generex Biotechnology Corp. at the 2011 San Antonio Breast Cancer Symposium from its continuing Phase II study of the li-Key hybrid-based HER2/neu peptide vaccine in HER2-expressing breast cancer patients.

  • Untitled.  // Diabetes Health;Jul2005, Vol. 14 Issue 7, p16 

    Interviews Gerald Bernstein, vice president of medical affairs at Generex Biotechnology, about the inhalable insulin Oral-lyn. Efforts of the company in seeking for the approval of Oral-lyn in the U.S.; Difference between insulin spray and inhaled insulin; Practical tips for people switching...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics